Related Experiment Video
Updated: Nov 16, 2025

Author Spotlight: Deciphering Coagulation Disorders in Traumatic Brain Injury Patients
Published on: August 4, 2023
Association of coagulation dysfunction with cardiac injury among hospitalized patients with COVID-19
Liang Chen1, Wei Hu2, Xiaoxiao Guo2
1State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Insights
Cardiac injury is a common COVID-19 complication linked to poor outcomes. This study found coagulation dysfunction, particularly elevated D-dimer levels, significantly associated with cardiac injury and mortality in hospitalized patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Hematology
Background:
- Cardiac injury is a frequent complication of coronavirus disease 2019 (COVID-19).
- It is associated with adverse clinical outcomes and increased in-hospital mortality.
- The relationship between cardiac injury and coagulation dysfunction in COVID-19 requires further elucidation.
Purpose of the Study:
- To investigate the association between cardiac injury and coagulation dysfunction in patients hospitalized with COVID-19.
- To identify risk factors for cardiac injury and in-hospital mortality in this cohort.
- To explore the role of coagulation parameters in the pathogenesis of COVID-19-related cardiac injury.
Main Methods:
- Retrospective analysis of 181 consecutive hospitalized COVID-19 patients.
- Assessment of cardiac biomarkers: high-sensitivity troponin I (hs-cTnI), myoglobin, and creatine kinase-myocardial band (CK-MB).
- Evaluation of clinical characteristics, coagulation parameters (including D-dimer), and in-hospital outcomes (discharge or death).
Main Results:
- Cardiac injury was present in 23.2% of patients.
- Old age, high leukocyte count, elevated aspartate transaminase (AST), D-dimer, and serum ferritin were significantly associated with cardiac injury.
- Old age and elevated D-dimer were independent predictors of in-hospital mortality. Interleukin-6 (IL-6) levels were not significantly different between groups.
- Progressive cardiac injury showed synchronous alterations with D-dimer levels.
Conclusions:
- Cardiac injury is a common complication of COVID-19 and an independent risk factor for in-hospital mortality.
- Coagulation dysfunction, particularly elevated D-dimer, plays a significant role in the pathogenesis of cardiac injury in COVID-19, potentially involving microvascular injury.
- Risk stratification for cardiac injury and mortality should consider age and coagulation parameters like D-dimer.
Abstract:
Cardiac injury is a common complication of the coronavirus disease 2019 (COVID-19), and is associated with adverse clinical outcomes. In this study, we aimed to reveal the association of cardiac injury with coagulation dysfunction. We enrolled 181 consecutive patients who were hospitalized with COVID-19, and studied the clinical characteristics and outcome of these patients. Cardiac biomarkers high-sensitivity troponin I (hs-cTnI), myohemoglobin and creatine kinase-myocardial band (CK-MB) were assessed in all patients. The clinical outcomes were defined as hospital discharge or death. The median age of the study cohort was 55 (IQR, 46-65) years, and 102 (56.4%) were males. Forty-two of the 181 patients (23.2%) had cardiac injury. Old age, high leukocyte count, and high levels of aspartate transaminase (AST), D-dimer and serum ferritin were significantly associated with cardiac injury. Multivariate regression analysis revealed old age and elevated D-dimer levels as being strong risk predictors of in-hospital mortality. Interleukin 6 (IL6) levels were comparable in patients with or without cardiac injury. Serial observations of coagulation parameters demonstrated highly synchronous alterations of D-dimer along with progression to cardiac injury. Cardiac injury is a common complication of COVID-19 and is an independent risk factor for in-hospital mortality. Old age, high leukocyte count, and high levels of AST, D-dimer and serum ferritin are significantly associated with cardiac injury, whereas IL6 are not. Therefore, the pathogenesis of cardiac injury in COVID-19 may be primarily due to coagulation dysfunction along with microvascular injury.
More Related Videos
Related Concept Videos
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Coagulation
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Rheumatic Heart Disease I: Introduction
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...

